Skip to main content
. 2017 Jul 31;8(49):86816–86827. doi: 10.18632/oncotarget.19735

Figure 1. Network evidence diagrams of PFS, OS, ORR, DCR, diarrhea/fatigue or asthenia, nausea or vomiting, decreased appetite and dyspnoea.

Figure 1

Note: PFS = progression-free survival; OS = overall survival; ORR = overall response rate; DCR = disease control rate.